Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 1984703, 10 pages
http://dx.doi.org/10.1155/2016/1984703
Research Article

Potential of Inducible Nitric Oxide Synthase as a Therapeutic Target for Allergen-Induced Airway Hyperresponsiveness: A Critical Connection to Nitric Oxide Levels and PARP Activity

1The Stanley Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
2Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy
3Microbiology and Immunology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
4Pulmonary/Critical Care and Allergy/Immunology Section, School of Medicine, Louisiana State University, New Orleans, LA 70112, USA
5Eosinophilic Disorder Center in the Section of Pulmonary Diseases, Tulane University School of Medicine, New Orleans, LA 70112, USA

Received 5 February 2016; Revised 11 May 2016; Accepted 22 May 2016

Academic Editor: Alex Kleinjan

Copyright © 2016 Salome’ V. Ibba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Moreno, J. C. Hogg, and P. D. Pare, “Mechanics of airway narrowing,” American Review of Respiratory Disease, vol. 133, no. 6, pp. 1171–1180, 1986. View at Google Scholar · View at Scopus
  2. Y. Bossé, P. D. Paré, and C. Y. Seow, “Airway wall remodeling in asthma: from the epithelial layer to the adventitia,” Current Allergy and Asthma Reports, vol. 8, no. 4, pp. 357–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Halwani, S. Al-Muhsen, and Q. Hamid, “Airway remodeling in asthma,” Current Opinion in Pharmacology, vol. 10, no. 3, pp. 236–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. S. Park, S. Y. Kim, S. R. Kim, and Y. C. Lee, “Targeting abnormal airway vascularity as a therapeutical strategy in asthma,” Respirology, vol. 15, no. 3, pp. 459–471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. C. B. Bårnes and C. S. Ulrik, “Asthma and adherence to inhaled corticosteroids: current status and future perspectives,” Respiratory Care, vol. 60, no. 3, pp. 455–468, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. B. N. Lambrecht and H. Hammad, “The immunology of asthma,” Nature Immunology, vol. 16, no. 1, pp. 45–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. L. R. DeNicola, N. Kissoon, L. J. Duckworth, K. V. Blake, S. P. Murphy, and P. E. Silkoff, “Exhaled nitric oxide as an indicator of severity of asthmatic inflammation,” Pediatric Emergency Care, vol. 16, no. 4, pp. 290–295, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. F. L. M. Ricciardolo, F. P. Nijkamp, and G. Folkerts, “Nitric Oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease,” Current Drug Targets, vol. 7, no. 6, pp. 721–735, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Kirkham and I. Rahman, “Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy,” Pharmacology and Therapeutics, vol. 111, no. 2, pp. 476–494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. W. MacNee, “Oxidative stress and lung inflammation in airways disease,” European Journal of Pharmacology, vol. 429, no. 1–3, pp. 195–207, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Beckman, “Understanding peroxynitrite biochemistry and its potential for treating human diseases,” Archives of Biochemistry and Biophysics, vol. 484, no. 2, pp. 114–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Sugiura and M. Ichinose, “Oxidative and nitrative stress in bronchial asthma,” Antioxidants and Redox Signaling, vol. 10, no. 4, pp. 785–797, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Yamamoto, Y. Tochino, K. Chibana, J. B. Trudeau, F. Holguin, and S. E. Wenzel, “Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation,” Clinical and Experimental Allergy, vol. 42, no. 5, pp. 760–768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. T. Hansel, S. A. Kharitonov, L. E. Donnelly et al., “A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics,” The FASEB Journal, vol. 17, no. 10, pp. 1298–1300, 2003. View at Google Scholar · View at Scopus
  15. S. A. Mulrennan and A. E. Redington, “Nitric oxide synthase inhibition: therapeutic potential in asthma,” Treatments in Respiratory Medicine, vol. 3, no. 2, pp. 79–88, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Brindicci, K. Ito, P. J. Barnes, and S. A. Kharitonov, “Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers,” Chest, vol. 132, no. 2, pp. 581–588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Singh, D. Richards, R. G. Knowles et al., “Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 10, pp. 988–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Islam, C. Breton, M. T. Salam et al., “Role of inducible nitric oxide synthase in asthma risk and lung function growth during adolescence,” Thorax, vol. 65, no. 2, pp. 139–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. S. Naura, M. Zerfaoui, H. Kim et al., “Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation,” Journal of Immunology, vol. 185, no. 5, pp. 3076–3085, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Naura, R. Datta, C. P. Hans et al., “Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia,” European Respiratory Journal, vol. 33, no. 2, pp. 252–261, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Ghonim, K. Pyakurel, S. V. Ibba et al., “PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice,” Clinical Science (London, England), vol. 129, no. 11, pp. 951–962, 2015. View at Publisher · View at Google Scholar
  22. M. A. Ghonim, K. Pyakurel, S. V. Ibba et al., “PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4+ T cell function,” Journal of Translational Medicine, vol. 13, no. 1, article 225, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Nathan, C. A. Sorkness, M. Kosinski et al., “Development of the asthma control test: a survey for assessing asthma control,” Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 59–65, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Bousquet, P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola, “Asthma: from bronchoconstriction to airways inflammation and remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1720–1745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. W. M. Moore, R. K. Webber, G. M. Jerome, F. S. Tjoeng, T. P. Misko, and M. G. Currie, “L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase,” Journal of Medicinal Chemistry, vol. 37, no. 23, pp. 3886–3888, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Cosby, K. S. Partovi, J. H. Crawford et al., “Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation,” Nature Medicine, vol. 9, no. 12, pp. 1498–1505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Gerard, “Asthmatics breathe easier when it's SNO-ing,” Science, vol. 308, no. 5728, pp. 1560–1561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Lane, D. Knight, S. Burgess et al., “Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath,” Thorax, vol. 59, no. 9, pp. 757–760, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Sugiura, Y. Komaki, A. Koarai, and M. Ichinose, “Nitrative stress in refractory asthma,” Journal of Allergy and Clinical Immunology, vol. 121, no. 2, pp. 355–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Voraphani, M. T. Gladwin, A. U. Contreras et al., “An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma,” Mucosal Immunology, vol. 7, no. 5, pp. 1175–1185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. W. W. Busse, “The relationship of airway hyperresponsiveness and airway inflammation: airway hyperresponsiveness in asthma: its measurement and clinical significance,” Chest, vol. 138, no. 2, supplement, pp. 4S–10S, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Duranski, J. J. M. Greer, A. Dejam et al., “Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1232–1240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Hamacher, K. Eichert, C. Braun et al., “Montelukast exerts no acute direct effect on NO synthases,” Pulmonary Pharmacology and Therapeutics, vol. 20, no. 5, pp. 525–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. S. Naura, C. P. Hans, M. Zerfaoui et al., “Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation,” Clinical and Experimental Allergy, vol. 38, no. 5, pp. 839–846, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Hamelmann, J. Schwarze, K. Takeda et al., “Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 3, pp. 766–775, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Zerfaoui, Y. Errami, A. S. Naura et al., “Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-κB upon TLR4 stimulation,” The Journal of Immunology, vol. 185, no. 3, pp. 1894–1902, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. R. A. Dweik, P. B. Boggs, S. C. Erzurum et al., “An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications,” American Journal of Respiratory and Critical Care Medicine, vol. 184, no. 5, pp. 602–615, 2011. View at Publisher · View at Google Scholar · View at Scopus